| Database ID | Agent | Target | Cancer Type | Detail |
| DB01021 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01022 | imatinib mesylate | Abl
Plateletderived growth factor receptor
Mast/stem cell growth factor receptor | ovarian, primary peritoneal, or fallopian tube carcinoma | view |
| DB01023 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01024 | ertumaxomab | Receptor proteintyrosine kinase erbB2
Tcell surface glycoprotein CD3 epsilon chain
CD3 | breast cancer | view |
| DB01025 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01026 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01027 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01028 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01029 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01030 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01031 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01032 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01033 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01034 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01035 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |